Prostaglandin D2
From DrugPedia: A Wikipedia for Drug discovery
|
Prostaglandin D2
| |
Systematic (IUPAC) name | |
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C20H32O5 |
Mol. mass | 352.47 |
SMILES | & |
Synonyms | PGD2 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects.
General Properties
*Molecular Weight
352.47
*Molecular Formula
C20H32O5
*IUPAC NAME
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
*Canonical Smiles
CCCCCC(C=CC1C(C(CC1=O)O)CC=CCCCC(=O)O)O
*Isomeric Smiles
CCCCC[C@@H](C=C[C@@H]1[C@H]([C@H](CC1=O)O)CC=C/CCCC(=O)O)O
PhysioChemical Properties
*Melting Point
*LogP
*Water Solubility